Medical & Reimbursement Policies
Medication Policies
- ALPHA 1 PROTEINASE INHIBITORS
- AMVUTTRA
- BOTULINUM TOXINS
- CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) IMMUNOTHERAPY
- CYTOKINE AND CAM ANTAGONISTS
- DUCHENNE MUSCULAR DYSTROPHY (DMD)
- ERYTHROPOIESIS STIMULATING AGENTS
- EVKEEZA (EVINACUMAB-DGNB)
- FABRY DISEASE MEDICATIONS
- GENE THERAPY AGENTS
- GIVLAARI (GIVOSIRAN)
- IMMUNE GLOBULINS
- LANTIDRA (DONISLECEL-JUJU)
- LUTATHERA (LUTETIUM LU 177 DOTATATE)
- LUXTURNA (VORETIGENE NEPARVOVEC-RZYL)
- MEDICAL NECESSITY MEDICATIONS
- MEDICAL STEP THERAPY
- NATALIZUMAB AND NATALIZUMAB BIOSIMILAR
- MYASTHENIA GRAVIS MEDICATIONS
- QALSODY
- RITUXIMAB PRODUCTS
- SANDOSTATIN LAR DEPOT
- TEPEZZA (TEPROTUMUMAB-TRBW)
- VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS (VEGF) AND VISUDYNE (VERTEPORFIN)
- YCANTH (CANTHARIDIN)
- ZOLGENSMA (ONASEMNOGENE ABEPARVOVEC-XIOI)
- ZULRESSO
